MAY 04, 2017 6:12 PM PDT

Banning trans fats may cut these hospital stays

People living in places with laws banning or limiting trans fats in foods have fewer hospitalizations for stroke and heart attack than people living in places without these restrictions, a new study suggests.

Trans fatty acids, or trans fats, are commonly found in foods such as chips, crackers, fried foods, and baked goods. Minimal amounts of trans fat intake are linked to greater risk of cardiovascular disease, the leading cause of death worldwide.

In recent years, localities like New York City enacted policies to reduce trans fats in restaurants and other eateries. In 2018, an FDA ban on partially hydrogenated oil in foods, which will nearly eliminate dietary trans fat, takes effect nationwide.

To study the impact of restricting trans fats, Eric Brandt and coauthors compared outcomes for people living in New York counties with and without the restrictions. Using data from the state department of health and census estimates between 2002 and 2013, the researchers focused on hospital admissions for heart attack and stroke.

They found that three or more years after the restrictions were implemented, people living in areas with restrictions had significantly fewer hospitalizations for heart attack and stroke based on trends in similarly urban areas without the restrictions. The decline for the combined conditions was 6.2 percent.

“It is a pretty substantial decline,” says Brandt, a clinical fellow in cardiovascular medicine at Yale School of Medicine. “Our study highlights the power of public policy to impact the cardiovascular health of a population. Trans fats are deleterious for cardiovascular health, and minimizing or eliminating them from the diet can substantially reduce rates of heart attack and stroke.”

The study results point to the possibility of much more widespread benefit as the FDA’s measure—which restricts trans fats in all food—are due to take effect in 2018, says Brandt.

“Even though some companies have reduced the amount of trans fat in food,” Brandt says, “current FDA labeling guidelines allow up to 0.49 grams of trans fat per serving to be labeled as 0 grams, leaving consumers to scour labels for hidden trans fats, usually labeled as partially hydrogenated oils.”

“With the upcoming FDA regulation, people need not be so vigilant. A nationwide trans fat ban is a win for the millions of people at risk for cardiovascular disease,” he adds.

This article was originally published on futurity.org

About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
SEP 29, 2020
Cell & Molecular Biology
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
SEP 29, 2020
What We Call Parkinson's Disease May Actually be Two Distinct Disorders
Researchers have used imaging tools to show that Parkinson's disease may actually be two different diseases, one that st ...
OCT 01, 2020
Health & Medicine
Menopausal Women Find Relief in Cannabis
OCT 01, 2020
Menopausal Women Find Relief in Cannabis
A growing number of women may be using cannabis for managing menopause symptoms, evidence from  the Midlife Women V ...
OCT 05, 2020
Microbiology
Deadly Microbe Linked to Childhood Brain Disorder
OCT 05, 2020
Deadly Microbe Linked to Childhood Brain Disorder
Pediatric hydrocephalus - excessive fluid on the brain of a child - has been connected to a bacterial pathogen.
OCT 13, 2020
Clinical & Molecular DX
Test for Diabetes Checks If the Liver Is Responding
OCT 13, 2020
Test for Diabetes Checks If the Liver Is Responding
Glucagon is a hormone that prevents blood glucose levels from dropping too low by stimulating the liver to convert store ...
OCT 17, 2020
Clinical & Molecular DX
Imaging Innovation Set to Ease the Pain of Osteoarthritis
OCT 17, 2020
Imaging Innovation Set to Ease the Pain of Osteoarthritis
In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness ...
Loading Comments...